Dr Reddy’s Laboratories informs about press release

28 Jan 2019 Evaluate

Dr Reddy’s Laboratories has informed about press release titled ‘Dr. Reddy's Laboratories and its US subsidiary, Promius Pharma, announce FDA approval for TOSYMRA (sumatriptan nasal spray) 10 mg, in the US market.

The above information is a part of company’s filings submitted to BSE.

 

Dr. Reddys Lab Share Price

1175.55 -10.90 (-0.92%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×